Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurocognitive dimensions of breast cancer and its treatment.

× No keyword cloud information.

5 in total

1. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.

Authors: Catherine E Jansen; Christine Miaskowski; Marylin Dodd; Glenna Dowling; Joel Kramer
Journal: Cancer Date: 2005-11-15 Impact factor: 6.860

Review 2. Candidate mechanisms for chemotherapy-induced cognitive changes.

Authors: Tim A Ahles; Andrew J Saykin
Journal: Nat Rev Cancer Date: 2007-03 Impact factor: 60.716

3. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.

Authors: Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal: Breast Cancer Res Treat Date: 2010-08-06 Impact factor: 4.872

4. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Authors: Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen
Journal: Hum Brain Mapp Date: 2010-07-28 Impact factor: 5.038

5. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors: Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal: J Clin Oncol Date: 2010-09-13 Impact factor: 44.544

5 in total

1. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

Authors: Brenna C McDonald; Susan K Conroy; Dori J Smith; John D West; Andrew J Saykin
Journal: Brain Behav Immun Date: 2012-05-18 Impact factor: 7.217

2. Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors: Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal: Brain Imaging Behav Date: 2013-12 Impact factor: 3.978

Review 3. Neuroimaging, cancer, and cognition: state of the knowledge.

Authors: Kelly N Holohan; Diane Von Ah; Brenna C McDonald; Andrew J Saykin
Journal: Semin Oncol Nurs Date: 2013-11 Impact factor: 2.315

4. Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats.

Authors: Grandhi Venkata Ramalingayya; Sri Pragnya Cheruku; Pawan G Nayak; Anoop Kishore; Rekha Shenoy; Chamallamudi Mallikarjuna Rao; Nandakumar Krishnadas
Journal: Drug Des Devel Ther Date: 2017-03-29 Impact factor: 4.162

5. The Development of a Mindfulness-Based Music Therapy (MBMT) Program for Women Receiving Adjuvant Chemotherapy for Breast Cancer.

Authors: Teresa Lesiuk
Journal: Healthcare (Basel) Date: 2016-08-09

5 in total